Cryo-Save Group N.V.: admission to aim with market capitalisation of £101.2M

November 1, 2007 Group News

Cryo-Save Group N.V. (“Cryo-Save”, “the Group” or “the Company”), Europe’s largest adult stem cell storage bank, is to be admitted to AIM with a market capitalisation of £101.17 million. The Group has raised £26.54 million, before expenses, via a placing of shares at 210p per share with institutional investors. Trading in Cryo-Save shares is expected to start on Tuesday 6 November 2007.

PDF Downloads

Related Articles